Literature DB >> 35308928

A Framework for Inferring Epidemiological Model Parameters using Bayesian Nonparametrics.

Oliver E Bent1, Charles Wachira1, Sekou L Remy1, William Ogallo1, Aisha Walcott-Bryant1.   

Abstract

The use of epidemiological models for decision-making has been prominent during the COVID-19 pandemic. Our work presents the application of nonparametric Bayesian techniques for inferring epidemiological model parameters based on available data sets published during the pandemic, towards enabling predictions under uncertainty during emerging pandemics. We present a methodology and framework that allows epidemiological model drivers to be integrated as input into the model calibration process. We demonstrate our methodology using the stringency index and mobility data for COVID-19 on an SEIRD compartmental model for selected US states. Our results directly compare the use of Bayesian nonparametrics for model predictions based on best parameter estimates with results of inference of parameter values across the US states. The proposed methodology provides a framework for What-If analysis and sequential decision-making methods for disease intervention planning and is demonstrated for COVID-19, while also applicable to other infectious disease models. ©2021 AMIA - All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35308928      PMCID: PMC8861664     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  26 in total

1.  Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.

Authors:  Seth Flaxman; Swapnil Mishra; Axel Gandy; H Juliette T Unwin; Thomas A Mellan; Helen Coupland; Charles Whittaker; Harrison Zhu; Tresnia Berah; Jeffrey W Eaton; Mélodie Monod; Azra C Ghani; Christl A Donnelly; Steven Riley; Michaela A C Vollmer; Neil M Ferguson; Lucy C Okell; Samir Bhatt
Journal:  Nature       Date:  2020-06-08       Impact factor: 49.962

2.  COVID-19 Government Response Event Dataset (CoronaNet v.1.0).

Authors:  Cindy Cheng; Joan Barceló; Allison Spencer Hartnett; Robert Kubinec; Luca Messerschmidt
Journal:  Nat Hum Behav       Date:  2020-06-23

3.  Comparative analysis and forecasting of COVID-19 cases in various European countries with ARIMA, NARNN and LSTM approaches.

Authors:  İsmail Kırbaş; Adnan Sözen; Azim Doğuş Tuncer; Fikret Şinasi Kazancıoğlu
Journal:  Chaos Solitons Fractals       Date:  2020-06-13       Impact factor: 5.944

Review 4.  Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development.

Authors:  Arash Keshavarzi Arshadi; Julia Webb; Milad Salem; Emmanuel Cruz; Stacie Calad-Thomson; Niloofar Ghadirian; Jennifer Collins; Elena Diez-Cecilia; Brendan Kelly; Hani Goodarzi; Jiann Shiun Yuan
Journal:  Front Artif Intell       Date:  2020-08-18

5.  An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19.

Authors:  Yiyue Ge; Tingzhong Tian; Suling Huang; Fangping Wan; Jingxin Li; Shuya Li; Xiaoting Wang; Hui Yang; Lixiang Hong; Nian Wu; Enming Yuan; Yunan Luo; Lili Cheng; Chengliang Hu; Yipin Lei; Hantao Shu; Xiaolong Feng; Ziyuan Jiang; Yunfu Wu; Ying Chi; Xiling Guo; Lunbiao Cui; Liang Xiao; Zeng Li; Chunhao Yang; Zehong Miao; Ligong Chen; Haitao Li; Hainian Zeng; Dan Zhao; Fengcai Zhu; Xiaokun Shen; Jianyang Zeng
Journal:  Signal Transduct Target Ther       Date:  2021-04-24

6.  Statistical Explorations and Univariate Timeseries Analysis on COVID-19 Datasets to Understand the Trend of Disease Spreading and Death.

Authors:  Ayan Chatterjee; Martin W Gerdes; Santiago G Martinez
Journal:  Sensors (Basel)       Date:  2020-05-29       Impact factor: 3.576

7.  Time series forecasting of COVID-19 transmission in Canada using LSTM networks.

Authors:  Vinay Kumar Reddy Chimmula; Lei Zhang
Journal:  Chaos Solitons Fractals       Date:  2020-05-08       Impact factor: 5.944

8.  Machine learning for clinical trials in the era of COVID-19.

Authors:  William R Zame; Ioana Bica; Cong Shen; Alicia Curth; Hyun-Suk Lee; Stuart Bailey; James Weatherall; David Wright; Frank Bretz; Mihaela van der Schaar
Journal:  Stat Biopharm Res       Date:  2020-08-18       Impact factor: 1.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.